Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hikma Pharmaceuticals Plc (OP: HKMPF )

28.14 UNCHANGED
Last Price Updated: 12:59 PM EST, Feb 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 28.14
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 28.14
Today's Range 28.14 - 28.14
52wk Range 22.33 - 28.14
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally. 
Via Benzinga
Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and... 
Via Benzinga

Performance

YTD
+12.48%
+12.48%
1 Month
+6.20%
+6.20%
3 Month
+15.01%
+15.01%
6 Month
+8.91%
+8.91%
1 Year
+6.20%
+6.20%

More News

Read More
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
Via Benzinga
Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion
Via Talk Markets
Up On Bad News
Via Talk Markets
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Rises Over 1%
Via Benzinga
Exposures Fossil Fuels
Hikma Bolsters Injectable Portfolio With $375M Custopharm Acquisition
Via Benzinga
Wonder Products
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.